12068289	11450	Maeda N	Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.	Nature medicine	2002	365
12451000	11450	Okamoto Y	Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2002	156
12802337	11450	Yamauchi T	Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.	Nature	2003	503
16306372	11450	Park SY	Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice.	Diabetes	2005	94
18158361	11450	Nishimura M	Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.	Circulation	2008	51
18375438	11450	Li M	Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.	Diabetes	2008	103
18426778	11450	Peterson SJ	L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice.	Journal of lipid research	2008	69
19043226	11450	Walsh K	Adipokines, myokines and cardiovascular disease.	Circulation journal 	2009	46
19168697	11450	Medoff BD	Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling.	American journal of respiratory cell and molecular biology	2009	59
20064576	11450	Cho AS	Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice.	Food and chemical toxicology 	2010	53
21041950	11450	Denzel MS	T-cadherin is critical for adiponectin-mediated cardioprotection in mice.	The Journal of clinical investigation	2010	71
21256905	11450	Xu J	Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.	Journal of hepatology	2011	45
22156343	11450	Konter JM	Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.	Journal of immunology	2012	32
23334396	11450	Rutkowski JM	Adiponectin promotes functional recovery after podocyte ablation.	Journal of the American Society of Nephrology 	2013	30
23524376	11450	Guo R	Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy.	Biochimica et biophysica acta	2013	31
24998914	11450	Cawthorn WP	Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction.	Cell metabolism	2014	64
25794851	11450	Lin Z	Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.	Circulation	2015	16
10375497	11475	Hellström M	Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse.	Development	1999	334
15389867	11475	Magness ST	A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.	Hepatology	2004	71
19085956	11475	Asahina K	Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development.	Hepatology	2009	55
23817022	11475	LeBleu VS	Origin and function of myofibroblasts in kidney fibrosis.	Nature medicine	2013	199
10716993	11482	Oh SP	Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2000	198
11062473	11482	Urness LD	Arteriovenous malformations in mice lacking activin receptor-like kinase-1.	Nature genetics	2000	107
11927558	11482	Goumans MJ	Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.	The EMBO journal	2002	281
17071723	11482	Alejandre-Alcázar MA	Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia.	American journal of physiology. Lung cellular and molecular physiology	2007	69
17911384	11482	Park SO	ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.	Blood	2008	78
19805914	11482	Park SO	Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia.	The Journal of clinical investigation	2009	73
20124460	11482	Mitchell D	ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.	Molecular cancer therapeutics	2010	45
11504952	11539	Sun D	Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors.	Proceedings of the National Academy of Sciences of the United States of America	2001	99
18056839	11539	Eckle T	A2B adenosine receptor dampens hypoxia-induced vascular leak.	Blood	2008	118
11171998	11554	Zhu WZ	Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes.	Proceedings of the National Academy of Sciences of the United States of America	2001	96
17038640	11554	Nikolaev VO	Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.	Circulation research	2006	91
10399917	11596	Hofmann MA	RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.	Cell	1999	404
11108954	11596	Schmidt AM	The biology of the receptor for advanced glycation end products and its ligands.	Biochimica et biophysica acta	2000	138
11287350	11596	Wautier MP	Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.	American journal of physiology. Endocrinology and metabolism	2001	148
12671045	11596	Sakaguchi T	Central role of RAGE-dependent neointimal expansion in arterial restenosis.	The Journal of clinical investigation	2003	87
12808450	11596	Deane R	RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.	Nature medicine	2003	288
14744997	11596	Palumbo R	Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation.	The Journal of cell biology	2004	119
18079965	11596	Harja E	Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.	The Journal of clinical investigation	2008	120
18403730	11596	Boyd JH	S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products.	Circulation research	2008	66
22406537	11596	Deane R	A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.	The Journal of clinical investigation	2012	83
22615109	11596	Carnevale D	Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.	Hypertension	2012	32
22915134	11596	Okuma Y	Anti-high mobility group box-1 antibody therapy for traumatic brain injury.	Annals of neurology	2012	36
25335802	11596	Alata W	Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice.	Journal of cerebral blood flow and metabolism 	2015	16
9204896	11600	Maisonpierre PC	Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.	Science	1997	575
9774272	11600	Suri C	Increased vascularization in mice overexpressing angiopoietin-1.	Science	1998	133
10617467	11600	Thurston G	Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.	Science	1999	298
12361603	11600	Gale NW	Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.	Developmental cell	2002	222
15687104	11600	Scharpfenecker M	The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism.	Journal of cell science	2005	91
17562701	11600	Mammoto T	Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo.	The Journal of biological chemistry	2007	57
18316578	11600	Fernando NT	Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.	Clinical cancer research 	2008	53
18382669	11600	Chen L	Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing.	PloS one	2008	327
21606590	11600	Jeansson M	Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.	The Journal of clinical investigation	2011	97
25821987	11600	Zhou BO	Hematopoietic stem and progenitor cells regulate the regeneration of their niche by secreting Angiopoietin-1.	eLife	2015	18
27548530	11600	Korhonen EA	Tie1 controls angiopoietin function in vascular remodeling and inflammation.	The Journal of clinical investigation	2016	10
16462802	11601	Fiedler U	Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.	Nature medicine	2006	213
16778080	11601	Lavine KJ	Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development.	Genes and development	2006	88
22343031	11601	Holopainen T	Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.	Journal of the National Cancer Institute	2012	55
25704811	11601	Keskin D	Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.	Cell reports	2015	29
25962877	11601	Choi HJ	Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2.	Nature communications	2015	21
11532901	11606	Rey FE	Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.	Circulation research	2001	168
12456490	11606	Zimmerman MC	Superoxide mediates the actions of angiotensin II in the central nervous system.	Circulation research	2002	110
12855482	11606	Saraff K	Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2003	110
15192025	11606	Zimmerman MC	Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.	Circulation research	2004	149
19073907	11606	Hoch NE	Regulation of T-cell function by endogenously produced angiotensin II.	American journal of physiology. Regulatory, integrative and comparative physiology	2009	89
19608970	11606	Police SB	Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.	Arteriosclerosis, thrombosis, and vascular biology	2009	60
20088827	11606	Daugherty A	Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.	Clinical science	2010	56
20147609	11606	Crowley SD	Lymphocyte responses exacerbate angiotensin II-dependent hypertension.	American journal of physiology. Regulatory, integrative and comparative physiology	2010	60
20305660	11606	Rudolph V	Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.	Nature medicine	2010	54
20676904	11606	Marsh SA	Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.	Amino acids	2011	38
21597004	11606	Burger D	Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts.	Arteriosclerosis, thrombosis, and vascular biology	2011	36
21785215	11606	Swaminathan PD	Oxidized CaMKII causes cardiac sinus node dysfunction in mice.	The Journal of clinical investigation	2011	74
23942363	11606	Toth P	Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension.	Journal of cerebral blood flow and metabolism 	2013	38
24718617	11606	Li L	Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.	PloS one	2014	20
25898844	11606	Lorenzen JM	Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.	European heart journal	2015	17
15596561	11607	Daugherty A	Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.	Circulation	2004	73
22610169	11607	Hilzendeger AM	A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity.	American journal of physiology. Heart and circulatory physiology	2012	32
25995315	11607	Pironti G	Circulating Exosomes Induced by Cardiac Pressure Overload Contain Functional Angiotensin II Type 1 Receptors.	Circulation	2015	20
21493863	11609	Habashi JP	Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.	Science	2011	114
10673259	11651	Fujio Y	Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.	Circulation	2000	192
11029009	11651	Simoncini T	Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase.	Nature	2000	237
11489933	11651	Llevadot J	HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.	The Journal of clinical investigation	2001	91
11909972	11651	Shioi T	Akt/protein kinase B promotes organ growth in transgenic mice.	Molecular and cellular biology	2002	124
11943770	11651	Matsui T	Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart.	The Journal of biological chemistry	2002	128
12237475	11651	Condorelli G	Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	122
12890675	11651	Kovacic S	Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart.	The Journal of biological chemistry	2003	100
14656927	11651	Wilkins BJ	Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.	Circulation research	2004	234
15148275	11651	Hiasa K	Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.	Circulation	2004	80
15713641	11651	Easton RM	Role for Akt3/protein kinase Bgamma in attainment of normal brain size.	Molecular and cellular biology	2005	183
16075055	11651	Shiojima I	Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.	The Journal of clinical investigation	2005	257
16075056	11651	Ackah E	Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.	The Journal of clinical investigation	2005	140
16636172	11651	DeBosch B	Akt1 is required for physiological cardiac growth.	Circulation	2006	143
16738242	11651	Wang L	Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration.	The Journal of neuroscience 	2006	95
16965940	11651	Noiseux N	Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.	Molecular therapy 	2006	117
16966610	11651	Hiroi Y	Rapid nongenomic actions of thyroid hormone.	Proceedings of the National Academy of Sciences of the United States of America	2006	78
17965779	11651	Li HH	Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.	The Journal of clinical investigation	2007	88
17997386	11651	Marone R	Targeting phosphoinositide 3-kinase: moving towards therapy.	Biochimica et biophysica acta	2008	156
18037896	11651	Muraski JA	Pim-1 regulates cardiomyocyte survival downstream of Akt.	Nature medicine	2007	88
18054314	11651	Fernández-Hernando C	Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease.	Cell metabolism	2007	94
18064042	11651	Miyamoto S	Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II.	Cell death and differentiation	2008	94
18845810	11651	Piantadosi CA	Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1.	Circulation research	2008	119
19147655	11651	Wright JJ	Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.	Cardiovascular research	2009	49
19151200	11651	Noyan-Ashraf MH	GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.	Diabetes	2009	109
19153269	11651	Sun Q	Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity.	Circulation	2009	128
19342603	11651	Symons JD	Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.	Circulation research	2009	56
20007913	11651	Durgan DJ	Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock.	Circulation research	2010	49
20074638	11651	Venkatesan B	WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.	Cellular signalling	2010	43
20237411	11651	Ren B	ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish.	The Journal of clinical investigation	2010	46
20404348	11651	Sayed D	MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand.	The Journal of biological chemistry	2010	85
22003059	11651	Chatterjee S	Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS.	American journal of physiology. Heart and circulatory physiology	2012	36
23149848	11651	Mosnier LO	Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.	Blood	2012	51
23399448	11651	Arslan F	Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury.	Stem cell research	2013	107
23901824	11651	Andres AM	Mitophagy is required for acute cardioprotection by simvastatin.	Antioxidants and redox signaling	2014	33
24498331	11651	Curran J	Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation.	PloS one	2014	24
26194913	11651	Yang WJ	Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis.	EMBO molecular medicine	2015	21
26354121	11651	Zhou H	Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
18596060	11669	Wenzel P	Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction.	Cardiovascular research	2008	60
19332462	11669	Doser TA	Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction.	Circulation	2009	76
20558439	11669	Chen CH	Mitochondrial aldehyde dehydrogenase and cardiac diseases.	Cardiovascular research	2010	45
20705694	11669	Ma H	Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde.	European heart journal	2011	60
24874076	11669	Guo Y	A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy.	Biochimica et biophysica acta	2015	15
1423598	11816	Plump AS	Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.	Cell	1992	419
8274468	11816	Nakashima Y	ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.	Arteriosclerosis and thrombosis 	1994	358
8274470	11816	Reddick RL	Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.	Arteriosclerosis and thrombosis 	1994	138
8656070	11816	Tangirala RK	Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.	Journal of lipid research	1995	117
9598845	11816	Nakashima Y	Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.	Arteriosclerosis, thrombosis, and vascular biology	1998	152
9732872	11816	Boring L	Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.	Nature	1998	335
10190883	11816	Moulton KS	Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.	Circulation	1999	98
10430941	11816	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	112
11120756	11816	Shibata M	Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.	The Journal of clinical investigation	2000	266
11238274	11816	Laursen JB	Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.	Circulation	2001	151
11282909	11816	von Hundelshausen P	RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.	Circulation	2001	86
11468208	11816	Kuhlencordt PJ	Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.	Circulation	2001	126
11701621	11816	Mallat Z	Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.	Circulation research	2001	102
11714743	11816	Barry-Lane PA	p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice.	The Journal of clinical investigation	2001	117
11748108	11816	Xu XH	Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.	Circulation	2001	131
11839631	11816	Weis M	Statins have biphasic effects on angiogenesis.	Circulation	2002	113
11854128	11816	Li L	Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model.	Circulation	2002	83
11901183	11816	Caligiuri G	Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.	The Journal of clinical investigation	2002	97
12057992	11816	Chen J	In vivo imaging of proteolytic activity in atherosclerosis.	Circulation	2002	82
12147534	11816	Ballinger SW	Mitochondrial integrity and function in atherogenesis.	Circulation	2002	92
12370251	11816	Massberg S	A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.	The Journal of experimental medicine	2002	120
12451010	11816	Bucciarelli LG	RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.	Circulation	2002	111
12483207	11816	Huo Y	Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.	Nature medicine	2003	180
12569158	11816	Lesnik P	Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.	The Journal of clinical investigation	2003	105
12615675	11816	Kirii H	Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2003	131
12682294	11816	Moulton KS	Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2003	125
12860902	11816	Rauscher FM	Aging, progenitor cell exhaustion, and atherosclerosis.	Circulation	2003	134
14744975	11816	Paul A	C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2004	71
15124016	11816	Hu Y	Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice.	The Journal of clinical investigation	2004	128
15131116	11816	Lund G	DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E.	The Journal of biological chemistry	2004	74
15249654	11816	Michelsen KS	Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.	Proceedings of the National Academy of Sciences of the United States of America	2004	257
15345516	11816	Brånén L	Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.	Arteriosclerosis, thrombosis, and vascular biology	2004	97
15567863	11816	Ricci R	Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.	Science	2004	80
15569838	11816	Ming XF	Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction.	Circulation	2004	77
15590644	11816	Hojjati MR	Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.	The Journal of biological chemistry	2005	66
15653572	11816	Kelly KA	Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.	Circulation research	2005	111
15761195	11816	Zernecke A	SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells.	Circulation research	2005	81
15772340	11816	Fryer JD	Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.	The Journal of neuroscience 	2005	95
15809369	11816	Zhou J	Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice.	Circulation	2005	92
16075060	11816	Moore KJ	Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.	The Journal of clinical investigation	2005	118
16103409	11816	Hermanowski-Vosatka A	11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.	The Journal of experimental medicine	2005	74
16221765	11816	Johnson JL	Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.	Proceedings of the National Academy of Sciences of the United States of America	2005	90
16414948	11816	Sun Q	Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model.	JAMA	2005	183
16682495	11816	Galkina E	Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent.	The Journal of experimental medicine	2006	141
16741184	11816	Stoll G	Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.	Stroke	2006	89
16840715	11816	Bennett BJ	Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.	Arteriosclerosis, thrombosis, and vascular biology	2006	67
16862155	11816	Wong CW	Connexin37 protects against atherosclerosis by regulating monocyte adhesion.	Nature medicine	2006	70
16892061	11816	Clarke MC	Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis.	Nature medicine	2006	135
17224478	11816	Aikawa E	Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease.	Circulation	2007	111
17229044	11816	Silva EA	Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis.	Journal of thrombosis and haemostasis 	2007	78
17272749	11816	Mor A	Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2007	63
17322176	11816	Stoneman V	Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques.	Circulation research	2007	72
17339547	11816	Hansmann G	Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.	Circulation	2007	122
17420349	11816	Lewis P	Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.	Circulation	2007	67
17420353	11816	Jaffer FA	Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.	Circulation	2007	71
17431486	11816	Li Z	Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes.	Environmental health perspectives	2007	56
17916769	11816	Sukhanov S	IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	58
17962629	11816	McAteer MA	Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide.	Arteriosclerosis, thrombosis, and vascular biology	2008	68
18079406	11816	Liu P	CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden.	Arteriosclerosis, thrombosis, and vascular biology	2008	52
18202315	11816	Araujo JA	Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress.	Circulation research	2008	121
18268038	11816	Miller AM	IL-33 reduces the development of atherosclerosis.	The Journal of experimental medicine	2008	149
18309100	11816	Ryoo S	Endothelial arginase II: a novel target for the treatment of atherosclerosis.	Circulation research	2008	73
18382765	11816	Hansmann G	An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.	The Journal of clinical investigation	2008	127
18541740	11816	Briley-Saebo KC	Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.	Circulation	2008	55
18688283	11816	Toyama K	The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.	The Journal of clinical investigation	2008	71
18689793	11816	Zhang QJ	Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice.	Cardiovascular research	2008	89
18769630	11816	Chun HJ	Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.	The Journal of clinical investigation	2008	62
18948635	11816	Manning-Tobin JJ	Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.	Arteriosclerosis, thrombosis, and vascular biology	2009	79
18988885	11816	Wang Y	Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.	Arteriosclerosis, thrombosis, and vascular biology	2009	60
19033669	11816	Deane R	apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.	The Journal of clinical investigation	2008	176
19046569	11816	Gareus R	Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.	Cell metabolism	2008	95
19139167	11816	Gräbner R	Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.	The Journal of experimental medicine	2009	80
19416717	11816	Thorp E	Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.	Cell metabolism	2009	114
19487682	11816	Peters D	Targeting atherosclerosis by using modular, multifunctional micelles.	Proceedings of the National Academy of Sciences of the United States of America	2009	59
19620505	11816	Croce K	Myeloid-related protein-8/14 is critical for the biological response to vascular injury.	Circulation	2009	62
19667236	11816	Norata GD	Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.	Circulation	2009	67
19816508	11816	Elia L	The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease.	Cell death and differentiation	2009	161
19836260	11816	Xie JJ	The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice.	Cytokine	2010	46
19837950	11816	Judkins CP	Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice.	American journal of physiology. Heart and circulatory physiology	2010	87
19897196	11816	Jun J	Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.	Atherosclerosis	2010	51
20068138	11816	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	96
20111605	11816	Khallou-Laschet J	Macrophage plasticity in experimental atherosclerosis.	PloS one	2010	139
20368519	11816	Smith E	Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.	Circulation	2010	120
20444418	11816	Rask-Madsen C	Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.	Cell metabolism	2010	80
20705925	11816	Mercer JR	DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome.	Circulation research	2010	43
20956207	11816	Drechsler M	Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis.	Circulation	2010	110
21041949	11816	Feig JE	LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.	The Journal of clinical investigation	2010	47
21471207	11816	Nishitsuji K	Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.	The Journal of biological chemistry	2011	46
21474820	11816	Madhur MS	Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2011	59
21482781	11816	Feig JE	HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	86
21505265	11816	Potteaux S	Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.	The Journal of clinical investigation	2011	93
21868694	11816	Kyaw T	B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.	Circulation research	2011	68
22116098	11816	Danzaki K	Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2012	39
22240132	11816	Matsubara J	A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.	Journal of the American College of Cardiology	2012	61
22302786	11816	Butcher MJ	The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.	Circulation research	2012	41
22394519	11816	Döring Y	Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice.	Circulation research	2012	39
22622580	11816	Bell RD	Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.	Nature	2012	216
22848551	11816	Hawkes CA	Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele.	PloS one	2012	40
22886300	11816	Koltsova EK	Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis.	The Journal of clinical investigation	2012	59
23103162	11816	Kothapalli D	Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.	Cell reports	2012	38
23224247	11816	Gorenne I	Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis.	Circulation	2013	38
23300273	11816	Majmudar MD	Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques.	Circulation research	2013	38
23337530	11816	Ervinna N	Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.	Endocrinology	2013	30
23349247	11816	Riwanto M	Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.	Circulation	2013	50
23349943	11816	Weng S	Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice.	PloS one	2013	27
23417922	11816	Soehnlein O	Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes.	EMBO molecular medicine	2013	26
23524964	11816	Martel C	Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice.	The Journal of clinical investigation	2013	52
23999527	11816	Hammer C	Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.	Molecular psychiatry	2014	54
24084690	11816	Sun X	Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.	Circulation research	2014	50
24425713	11816	Knight JS	Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.	Circulation research	2014	40
24952646	11816	Heidt T	Chronic variable stress activates hematopoietic stem cells.	Nature medicine	2014	75
24990232	11816	Di Gregoli K	MicroRNA-24 regulates macrophage behavior and retards atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2014	20
25070003	11816	Feil S	Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis.	Circulation research	2014	53
25552357	11816	Clement M	Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development.	Circulation	2015	16
25675483	11816	Han BH	Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.	Proceedings of the National Academy of Sciences of the United States of America	2015	24
25757756	11816	Halliday MR	Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.	Journal of cerebral blood flow and metabolism 	2016	35
25801675	11816	Zhang Y	MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.	Scientific reports	2015	18
26084025	11816	Hu D	Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors.	Immunity	2015	23
26322175	11816	Husain K	Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.	World journal of biological chemistry	2015	18
26385958	11816	Schürmann C	The NADPH oxidase Nox4 has anti-atherosclerotic functions.	European heart journal	2015	17
26699388	11816	Organ CL	Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.	Circulation. Heart failure	2016	16
26715682	11816	Gray SP	Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.	Arteriosclerosis, thrombosis, and vascular biology	2016	15
12578959	11829	Amiry-Moghaddam M	An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain.	Proceedings of the National Academy of Sciences of the United States of America	2003	95
16303850	11829	Saadoun S	Involvement of aquaporin-4 in astroglial cell migration and glial scar formation.	Journal of cell science	2005	115
16564496	11829	Verkman AS	Three distinct roles of aquaporin-4 in brain function revealed by knockout mice.	Biochimica et biophysica acta	2006	74
19345723	11829	Saadoun S	AQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology.	Neuroscience	2009	45
21257712	11829	Li L	Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation.	FASEB journal 	2011	42
21298100	11829	Li SY	Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury.	PloS one	2011	37
21990350	11829	Haj-Yasein NN	Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet.	Proceedings of the National Academy of Sciences of the United States of America	2011	52
24583950	11829	Yao Y	Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity.	Nature communications	2014	21
16469861	11848	Noma K	Physiological role of ROCKs in the cardiovascular system.	American journal of physiology. Cell physiology	2006	108
16574914	11848	Brown JH	The Rac and Rho hall of fame: a decade of hypertrophic signaling hits.	Circulation research	2006	90
21177343	11848	Li D	Dishevelled-associated activator of morphogenesis 1 (Daam1) is required for heart morphogenesis.	Development	2011	37
22278020	11848	Wang L	Mechanisms of the proteinuria induced by Rho GTPases.	Kidney international	2012	35
23040068	11848	Pelham CJ	Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.	Cell metabolism	2012	32
19451351	11938	Dai DF	Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging.	Circulation	2009	142
19520971	11938	Koitabashi N	Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.	Circulation research	2009	68
20382344	11938	Dai DF	Cardiac aging in mice and humans: the role of mitochondrial oxidative stress.	Trends in cardiovascular medicine	2009	60
10436164	12091	Asahara T	Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.	Circulation research	1999	544
10952959	12091	Lee RJ	VEGF gene delivery to myocardium: deleterious effects of unregulated expression.	Circulation	2000	129
16450386	12091	Alva JA	VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells.	Developmental dynamics 	2006	143
15073151	12154	Chen H	BMP10 is essential for maintaining cardiac growth during murine cardiogenesis.	Development	2004	106
22158708	12154	He A	Polycomb repressive complex 2 regulates normal development of the mouse heart.	Circulation research	2012	46
22566602	12154	Ricard N	BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.	Blood	2012	59
10499585	12159	Lu MF	Function of Rieger syndrome gene in left-right asymmetry and craniofacial development.	Nature	1999	113
11485993	12159	Rossi JM	Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm.	Genes and development	2001	136
12975322	12159	Jiao K	An essential role of Bmp4 in the atrioventricular septation of the mouse heart.	Genes and development	2003	116
15388638	12159	Sorescu GP	Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase.	Circulation research	2004	115
18000065	12159	Klaus A	Distinct roles of Wnt/beta-catenin and Bmp signaling during early cardiogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2007	72
19509466	12159	High FA	Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development.	The Journal of clinical investigation	2009	50
20551377	12159	Ni CW	Discovery of novel mechanosensitive genes in vivo using mouse carotid artery endothelium exposed to disturbed flow.	Blood	2010	58
21836062	12159	Rufaihah AJ	Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.	Arteriosclerosis, thrombosis, and vascular biology	2011	66
15031260	12168	West J	Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.	Circulation research	2004	75
16497988	12168	Long L	Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.	Circulation research	2006	69
18663089	12168	Hong KH	Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.	Circulation	2008	66
18723761	12168	West J	Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions.	American journal of physiology. Lung cellular and molecular physiology	2008	55
22180660	12168	Johnson JA	Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension.	American journal of physiology. Lung cellular and molecular physiology	2012	37
22450430	12168	Brock M	AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.	European heart journal	2014	39
23867624	12168	Spiekerkoetter E	FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.	The Journal of clinical investigation	2013	62
27045138	12168	Hopper RK	In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.	Circulation	2016	13
16648270	12288	Balijepalli RC	Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation.	Proceedings of the National Academy of Sciences of the United States of America	2006	129
19383796	12288	Chopra N	Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
20169111	12288	Hong TT	BIN1 localizes the L-type calcium channel to cardiac T-tubules.	PLoS biology	2010	60
21111744	12288	Chen X	Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy.	Journal of molecular and cellular cardiology	2011	35
22133878	12288	Goonasekera SA	Decreased cardiac L-type Ca²⁺ channel activity induces hypertrophy and heart failure in mice.	The Journal of clinical investigation	2012	46
19276108	12323	Wu Y	Calmodulin kinase II is required for fight or flight sinoatrial node physiology.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
19381018	12323	Ling H	Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.	The Journal of clinical investigation	2009	128
19850941	12323	Palomeque J	Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species.	Circulation research	2009	52
19919992	12323	Sag CM	Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure.	Circulation. Heart failure	2009	55
23426181	12323	Luo M	Diabetes increases mortality after myocardial infarction by oxidizing CaMKII.	The Journal of clinical investigation	2013	62
24077098	12323	Erickson JR	Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.	Nature	2013	101
12208807	12325	Wu Y	Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy.	Circulation	2002	92
16840718	12325	Guo T	Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes.	Circulation research	2006	101
23051746	12325	Joiner ML	CaMKII determines mitochondrial stress responses in heart.	Nature	2012	81
23388157	12325	Ling H	Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB.	Circulation research	2013	30
24421356	12325	Morotti S	A novel computational model of mouse myocyte electrophysiology to assess the synergy between Na+ loading and CaMKII.	The Journal of physiology	2014	24
24643800	12325	Jian Z	Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling.	Science signaling	2014	28
25124496	12325	Kreusser MM	Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.	Circulation	2014	21
15879174	12359	Schriner SE	Extension of murine life span by overexpression of catalase targeted to mitochondria.	Science	2005	443
20456298	12359	Dai DF	Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria.	Aging cell	2010	66
23204527	12359	Rindler PM	High dietary fat selectively increases catalase expression within cardiac mitochondria.	The Journal of biological chemistry	2013	25
16932808	12373	Knollmann BC	Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.	The Journal of clinical investigation	2006	158
21983287	12373	Kornyeyev D	Calsequestrin 2 deletion shortens the refractoriness of Ca²⁺ release and reduces rate-dependent Ca²⁺-alternans in intact mouse hearts.	Journal of molecular and cellular cardiology	2012	33
24216388	12373	Glukhov AV	Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1.	European heart journal	2015	24
12138167	12391	Woodman SE	Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.	The Journal of biological chemistry	2002	99
25694588	12391	Sun J	Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria.	Cardiovascular research	2015	17
9616148	12490	Möhle R	The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.	Blood	1998	109
10688823	12490	Drake CJ	Vasculogenesis in the day 6.5 to 9.5 mouse embryo.	Blood	2000	102
12015303	12490	Minasi MG	The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues.	Development	2002	107
12702503	12490	Heeschen C	Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.	Blood	2003	136
14568894	12490	Yeh ET	Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo.	Circulation	2003	83
15238461	12490	Miranville A	Improvement of postnatal neovascularization by human adipose tissue-derived stem cells.	Circulation	2004	161
15297308	12490	Kawada H	Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction.	Blood	2004	113
15550692	12490	Kucia M	Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction.	Circulation research	2004	83
16224047	12490	Nakagami H	Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.	Arteriosclerosis, thrombosis, and vascular biology	2005	93
17389330	12490	Nishimura S	Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels.	Diabetes	2007	123
17882221	12490	Seandel M	Generation of functional multipotent adult stem cells from GPR125+ germline progenitors.	Nature	2007	116
19635599	12490	Webber MJ	Development of bioactive peptide amphiphiles for therapeutic cell delivery.	Acta biomaterialia	2010	52
19779618	12490	Davis DR	Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue.	PloS one	2009	89
19853564	12490	Strilić B	The molecular basis of vascular lumen formation in the developing mouse aorta.	Developmental cell	2009	105
20977627	12490	Bani D	Telocytes as supporting cells for myocardial tissue organization in developing and adult heart.	Journal of cellular and molecular medicine	2010	42
10772654	12491	Podrez EA	Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.	The Journal of clinical investigation	2000	105
10913136	12491	Coburn CT	Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.	The Journal of biological chemistry	2000	125
12145296	12491	Podrez EA	A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.	The Journal of biological chemistry	2002	121
18065445	12491	Kuchibhotla S	Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II.	Cardiovascular research	2008	55
19065049	12491	Park YM	CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.	The Journal of clinical investigation	2009	110
20978343	12491	Li W	CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.	The Journal of clinical investigation	2010	43
21610069	12491	Tran TT	Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis.	The Journal of biological chemistry	2011	35
23382216	12491	Park L	Innate immunity receptor CD36 promotes cerebral amyloid angiopathy.	Proceedings of the National Academy of Sciences of the United States of America	2013	35
10449777	12562	Corada M	Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo.	Proceedings of the National Academy of Sciences of the United States of America	1999	155
17846325	12562	Li Z	Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease.	Circulation	2007	80
20395410	12562	Sakai VT	SHED differentiate into functional odontoblasts and endothelium.	Journal of dental research	2010	45
21364991	12562	Fujiwara M	Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A.	PloS one	2011	37
21857650	12562	Schulte D	Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability.	The EMBO journal	2011	66
23122290	12562	Li Z	Mouse embryonic head as a site for hematopoietic stem cell development.	Cell stem cell	2012	33
23863896	12562	Gordon-Keylock S	Mouse extraembryonic arterial vessels harbor precursors capable of maturing into definitive HSCs.	Blood	2013	26
25584796	12562	Birdsey GM	The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling.	Developmental cell	2015	26
25752958	12562	Yamamoto H	Integrin β1 controls VE-cadherin localization and blood vessel stability.	Nature communications	2015	22
10508865	12741	Morita K	Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells.	The Journal of cell biology	1999	152
12743111	12741	Nitta T	Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice.	The Journal of cell biology	2003	328
15689955	12741	Stamatovic SM	Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.	Journal of cerebral blood flow and metabolism 	2005	114
18187566	12741	Yamamoto M	Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells.	The American journal of pathology	2008	65
18344992	12741	Zhong Z	ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.	Nature neuroscience	2008	99
18799677	12741	McColl BW	Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.	The Journal of neuroscience 	2008	97
21857898	12741	Feng S	Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.	PloS one	2011	42
24522913	12741	Chai Q	Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.	Journal of virology	2014	22
25411471	12741	Braniste V	The gut microbiota influences blood-brain barrier permeability in mice.	Science translational medicine	2014	98
8757135	12767	Nagasawa T	Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.	Nature	1996	441
9634237	12767	Tachibana K	The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.	Nature	1998	312
12122049	12767	Stumm RK	A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia.	The Journal of neuroscience 	2002	86
15533866	12767	Abbott JD	Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.	Circulation	2004	202
17646584	12767	Hu X	Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.	Circulation	2007	84
17804806	12767	Sierro F	Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.	Proceedings of the National Academy of Sciences of the United States of America	2007	164
18427137	12767	Saxena A	Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction.	Circulation	2008	59
19407239	12767	Tang YL	Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.	Circulation research	2009	116
19996457	12767	Zernecke A	Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection.	Science signaling	2009	279
20437584	12767	Fan Y	Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.	Annals of neurology	2010	81
22634564	12767	Drukker M	Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells.	Nature biotechnology	2012	34
22685115	12767	Dong F	Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.	Circulation	2012	39
25621952	12767	Rafii S	Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration.	Nature cell biology	2015	21
26058075	12767	Pitt LA	CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.	Cancer cell	2015	29
26798014	12767	Tsai HH	Oligodendrocyte precursors migrate along vasculature in the developing nervous system.	Science	2016	23
16574901	12772	Zhou L	Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction.	Circulation research	2006	69
17332467	12772	Dimitrijevic OB	Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice.	Stroke	2007	84
18522849	12772	Belema-Bedada F	Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2.	Cell stem cell	2008	68
21060874	12772	Saederup N	Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice.	PloS one	2010	143
22190370	12772	Terrando N	Resolving postoperative neuroinflammation and cognitive decline.	Annals of neurology	2011	74
24695541	12772	Morganti JM	Cranial irradiation alters the brain's microenvironment and permits CCR2+ macrophage infiltration.	PloS one	2014	21
25337873	12772	Bonapace L	Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.	Nature	2014	70
25957903	12772	Dutta P	Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells.	Cell stem cell	2015	20
27444755	12772	Sager HB	Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.	Circulation research	2016	18
21244679	12822	Efimenko A	Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning.	Journal of translational medicine	2011	51
22479323	12822	Givvimani S	Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure.	PloS one	2012	40
23184933	12822	Margariti A	XBP1 mRNA splicing triggers an autophagic response in endothelial cells through BECLIN-1 transcriptional activation.	The Journal of biological chemistry	2013	35
11440982	12955	Wang X	Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice.	Circulation research	2001	105
18621691	12955	Tannous P	Autophagy is an adaptive response in desmin-related cardiomyopathy.	Proceedings of the National Academy of Sciences of the United States of America	2008	82
21659648	12955	Zheng Q	Autophagy and p62 in cardiac proteinopathy.	Circulation research	2011	59
9039266	13009	Arber S	MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.	Cell	1997	169
14966518	13009	Braz JC	PKC-alpha regulates cardiac contractility and propensity toward heart failure.	Nature medicine	2004	169
15843400	13046	Ho TH	Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.	Human molecular genetics	2005	85
16878132	13046	Mahadevan MS	Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy.	Nature genetics	2006	73
17823658	13046	Wang GS	Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.	The Journal of clinical investigation	2007	70
17936705	13046	Kuyumcu-Martinez NM	Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.	Molecular cell	2007	147
19075228	13046	Kalsotra A	A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.	Proceedings of the National Academy of Sciences of the United States of America	2008	160
24752171	13046	Giudice J	Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development.	Nature communications	2014	29
25883322	13046	Wang ET	Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.	Genome research	2015	25
12967772	13058	Cai H	The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.	Trends in pharmacological sciences	2003	142
14551238	13058	Byrne JA	Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.	Circulation research	2003	102
15867174	13058	Tojo T	Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.	Circulation	2005	92
16085672	13058	Liu JQ	Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox).	American journal of physiology. Lung cellular and molecular physiology	2006	102
17429347	13058	Park L	Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain.	Journal of cerebral blood flow and metabolism 	2007	76
17916764	13058	Kahles T	NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke.	Stroke	2007	106
18180403	13058	Looi YH	Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction.	Hypertension	2008	67
18378574	13058	Al-Shabrawey M	Role of NADPH oxidase in retinal vascular inflammation.	Investigative ophthalmology and visual science	2008	64
18583711	13058	Urao N	Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia.	Circulation research	2008	67
19096031	13058	Bae YS	Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2.	Circulation research	2009	94
20877715	13058	Kleinschnitz C	Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.	PLoS biology	2010	111
20884632	13058	Zhao Y	Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.	Cancer research	2010	46
21302291	13058	Yuan G	Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia.	Journal of cellular physiology	2011	62
21528437	13058	Murdoch CE	Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction.	Basic research in cardiology	2011	37
21903813	13058	Prosser BL	X-ROS signaling: rapid mechano-chemo transduction in heart.	Science	2011	133
22549734	13058	Youn JY	The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.	Diabetologia	2012	31
22747566	13058	Zhang M	NADPH oxidases in heart failure: poachers or gamekeepers?	Antioxidants and redox signaling	2013	37
23100220	13058	Nlandu Khodo S	NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury.	Journal of the American Society of Nephrology 	2012	31
23348743	13058	Gandhirajan RK	Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation.	The Journal of clinical investigation	2013	46
24081881	13058	Sciarretta S	Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2α/activating transcription factor 4 pathway.	Circulation research	2013	36
24424382	13058	Yang F	NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke.	Journal of cerebral blood flow and metabolism 	2014	26
25341795	13058	Karbach S	Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.	Arteriosclerosis, thrombosis, and vascular biology	2014	23
25529920	13058	Jaishy B	Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity.	Journal of lipid research	2015	16
15191949	13346	Rajantie I	Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells.	Blood	2004	106
20601385	13346	Tang M	Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts.	Cardiovascular research	2010	41
20829328	13346	Lockman PR	Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.	Clinical cancer research 	2010	120
21841311	13346	Li J	Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice.	The Journal of clinical investigation	2011	59
27102488	13346	Robison P	Detyrosinated microtubules buckle and bear load in contracting cardiomyocytes.	Science	2016	11
3319190	13405	Hoffman EP	Dystrophin: the protein product of the Duchenne muscular dystrophy locus.	Cell	1987	830
19277018	13405	Wu B	Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice.	Molecular therapy 	2009	61
19288467	13405	Yokota T	Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs.	Annals of neurology	2009	110
19759562	13405	Wu B	Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino.	Gene therapy	2010	44
20170628	13405	Moulton HM	Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.	Biochimica et biophysica acta	2010	48
21505427	13405	Yin H	Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.	Molecular therapy 	2011	41
21768542	13405	Rafael-Fortney JA	Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.	Circulation	2011	35
25642938	13405	Goyenvalle A	Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.	Nature medicine	2015	41
26721683	13405	Long C	Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.	Science	2016	104
26721686	13405	Tabebordbar M	In vivo gene editing in dystrophic mouse muscle and muscle stem cells.	Science	2016	110
11032855	13609	Liu Y	Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.	The Journal of clinical investigation	2000	275
15138255	13609	Kono M	The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis.	The Journal of biological chemistry	2004	122
16314531	13609	Mizugishi K	Essential role for sphingosine kinases in neural and vascular development.	Molecular and cellular biology	2005	201
17363629	13609	Pappu R	Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.	Science	2007	267
18258856	13609	Venkataraman K	Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.	Circulation research	2008	137
19282351	13609	Means CK	Sphingosine-1-phosphate receptor signalling in the heart.	Cardiovascular research	2009	51
19749179	13609	Sammani S	Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung.	American journal of respiratory cell and molecular biology	2010	47
25831442	13609	Proia RL	Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.	The Journal of clinical investigation	2015	47
1310132	13614	Ihara M	Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.	Life sciences	1992	131
20497976	13614	Widyantoro B	Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.	Circulation	2010	73
24590287	13614	Daehn I	Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.	The Journal of clinical investigation	2014	47
9630219	13642	Wang HU	Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.	Cell	1998	343
20445540	13642	Sawamiphak S	Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.	Nature	2010	151
21765212	13642	Bazigou E	Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice.	The Journal of clinical investigation	2011	50
23492730	13642	Kida Y	EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.	Journal of the American Society of Nephrology 	2013	30
9607766	13717	Li DY	Elastin is an essential determinant of arterial morphogenesis.	Nature	1998	151
12466207	13717	Karnik SK	A critical role for elastin signaling in vascular morphogenesis and disease.	Development	2003	94
15863465	13717	Wagenseil JE	Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries.	American journal of physiology. Heart and circulatory physiology	2005	70
20019329	13717	Huang J	Fibulin-4 deficiency results in ascending aortic aneurysms: a potential link between abnormal smooth muscle cell phenotype and aneurysm progression.	Circulation research	2010	46
21305018	13717	Ott CE	MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3' UTR and coding-sequence binding sites.	PloS one	2011	37
23714110	13717	Donato AJ	Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice.	Aging cell	2013	28
10348742	13805	Li DY	Defective angiogenesis in mice lacking endoglin.	Science	1999	190
10625534	13805	Arthur HM	Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.	Developmental biology	2000	111
20224041	13805	Mahmoud M	Pathogenesis of arteriovenous malformations in the absence of endoglin.	Circulation research	2010	59
20364125	13805	Lebrin F	Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.	Nature medicine	2010	62
23401487	13805	Anderberg C	Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination.	The Journal of experimental medicine	2013	29
16857962	13850	Seubert JM	Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.	Circulation research	2006	78
17440491	13850	Zhang W	Soluble epoxide hydrolase: a novel therapeutic target in stroke.	Journal of cerebral blood flow and metabolism 	2007	85
18927469	13850	Hercule HC	Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice.	Arteriosclerosis, thrombosis, and vascular biology	2009	45
22182838	13850	Panigrahy D	Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.	The Journal of clinical investigation	2012	69
15546004	14118	Ng CM	TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.	The Journal of clinical investigation	2004	165
16407178	14118	Carta L	Fibrillins 1 and 2 perform partially overlapping functions during aortic development.	The Journal of biological chemistry	2006	76
16601194	14118	Habashi JP	Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.	Science	2006	370
19635970	14118	Matt P	Circulating transforming growth factor-beta in Marfan syndrome.	Circulation	2009	53
22116819	14118	Merk DR	miR-29b participates in early aneurysm development in Marfan syndrome.	Circulation research	2012	40
9647657	14173	Seghezzi G	Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis.	The Journal of cell biology	1998	132
12183663	14173	Wood J	Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.	The Journal of pharmacology and experimental therapeutics	2002	94
15023891	14173	Kinnaird T	Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.	Circulation	2004	310
15558023	14173	Kishimoto K	Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis.	Oncogene	2005	73
17909625	14173	Nissen LJ	Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.	The Journal of clinical investigation	2007	75
10082563	14219	Babic AM	Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo.	Molecular and cellular biology	1999	109
11744618	14219	Inoki I	Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.	FASEB journal 	2002	101
12114504	14219	Hashimoto G	Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.	The Journal of biological chemistry	2002	95
20213804	14219	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	53
22363445	14219	Hall-Glenn F	CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis.	PloS one	2012	36
7596436	14254	Fong GH	Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.	Nature	1995	412
9689083	14254	Hiratsuka S	Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.	Proceedings of the National Academy of Sciences of the United States of America	1998	209
9826710	14254	Cao Y	Vascular endothelial growth factor C induces angiogenesis in vivo.	Proceedings of the National Academy of Sciences of the United States of America	1998	112
11689883	14254	Lyden D	Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.	Nature medicine	2001	383
12574630	14254	LeCouter J	Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.	Science	2003	131
12796773	14254	Autiero M	Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.	Nature medicine	2003	151
16436677	14254	Maharaj AS	Vascular endothelial growth factor localization in the adult.	The American journal of pathology	2006	66
16754748	14254	Li B	VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.	FASEB journal 	2006	77
17389265	14254	Cudmore M	Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.	Circulation	2007	96
21623369	14254	Stefater JA 3rd	Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells.	Nature	2011	85
24332967	14254	Schoors S	Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.	Cell metabolism	2014	53
25991856	14254	Yang X	VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patients.	Proceedings of the National Academy of Sciences of the United States of America	2015	18
9136932	14463	Kuo CT	GATA4 transcription factor is required for ventral morphogenesis and heart tube formation.	Genes and development	1997	238
9136933	14463	Molkentin JD	Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.	Genes and development	1997	263
15100413	14463	Aries A	Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity.	Proceedings of the National Academy of Sciences of the United States of America	2004	86
15249177	14463	Pikkarainen S	GATA transcription factors in the developing and adult heart.	Cardiovascular research	2004	88
15902305	14463	Zeisberg EM	Morphogenesis of the right ventricle requires myocardial expression of Gata4.	The Journal of clinical investigation	2005	81
16514068	14463	Oka T	Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.	Circulation research	2006	138
16847256	14463	Xin M	A threshold of GATA4 and GATA6 expression is required for cardiovascular development.	Proceedings of the National Academy of Sciences of the United States of America	2006	62
17947800	14463	Limana F	Identification of myocardial and vascular precursor cells in human and mouse epicardium.	Circulation research	2007	67
17975667	14463	Heineke J	Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart.	The Journal of clinical investigation	2007	69
18400219	14463	Zhao R	Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice.	Developmental biology	2008	67
19084512	14463	Maitra M	Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development.	Developmental biology	2009	45
20691899	14463	Ieda M	Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.	Cell	2010	640
20833366	14463	Trivedi CM	Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation.	Developmental cell	2010	40
21379568	14463	Schlesinger J	The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs.	PLoS genetics	2011	72
21433223	14463	Acquistapace A	Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer.	Stem cells	2011	42
22575762	14463	Protze S	A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.	Journal of molecular and cellular cardiology	2012	62
22581928	14463	Chen JX	Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5.	Circulation research	2012	83
22660318	14463	Song K	Heart repair by reprogramming non-myocytes with cardiac transcription factors.	Nature	2012	303
22931955	14463	Inagawa K	Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5.	Circulation research	2012	68
23591016	14463	Addis RC	Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success.	Journal of molecular and cellular cardiology	2013	54
23704920	14463	Christoforou N	Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming.	PloS one	2013	42
24091702	14463	Kasahara A	Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling.	Science	2013	54
24319660	14463	Fu JD	Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state.	Stem cell reports	2013	89
24586958	14463	Ifkovits JL	Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes.	PloS one	2014	30
25344074	14463	Nam YJ	Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors.	Development	2014	24
11161575	14609	Kisanuki YY	Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.	Developmental biology	2001	427
11179202	14609	Gutstein DE	Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43.	Circulation research	2001	167
14967725	14609	van Rijen HV	Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43.	Circulation	2004	75
15499029	14609	Danik SB	Modulation of cardiac gap junction expression and arrhythmic susceptibility.	Circulation research	2004	82
18003637	14609	Dobrowolski R	The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans.	Human molecular genetics	2008	60
19729017	14609	Jansen JA	Cardiac connexins and impulse propagation.	Journal of molecular and cellular cardiology	2010	47
22328533	14609	Smyth JW	Actin cytoskeleton rest stops regulate anterograde traffic of connexin 43 vesicles to the plasma membrane.	Circulation research	2012	38
22472609	14609	Ezan P	Deletion of astroglial connexins weakens the blood-brain barrier.	Journal of cerebral blood flow and metabolism 	2012	37
23186644	14609	Noyan-Ashraf MH	A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.	Circulation	2013	45
23559673	14609	Sovari AA	Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death.	Circulation. Arrhythmia and electrophysiology	2013	26
25771952	14609	George SA	Extracellular sodium and potassium levels modulate cardiac conduction in mice heterozygous null for the Connexin43 gene.	Pflugers Archiv 	2015	16
11572777	14613	Bruneau BG	A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease.	Cell	2001	236
17823370	14613	Mommersteeg MT	Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium.	Circulation research	2007	92
17932328	14613	Tallini YN	Propagated endothelial Ca2+ waves and arteriolar dilation in vivo: measurements in Cx40BAC GCaMP2 transgenic mice.	Circulation research	2007	67
20530546	14613	Buschmann I	Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow-driven arteriogenesis.	Development	2010	41
9171826	15110	Srivastava D	Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND.	Nature genetics	1997	108
9500551	15110	Riley P	The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis.	Nature genetics	1998	111
10021345	15110	Tanaka M	The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development.	Development	1999	144
15576406	15110	McFadden DG	The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner.	Development	2005	98
10074486	15251	Yu AY	Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha.	The Journal of clinical investigation	1999	168
18184809	15251	Wan C	Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2008	102
18606865	15251	Granger A	Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice.	FASEB journal 	2008	74
19490906	15251	Krishnan J	Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy.	Cell metabolism	2009	71
20332345	15251	Li J	Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.	Diabetes	2010	53
20427574	15251	Diebold I	The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1.	Molecular biology of the cell	2010	77
22484816	15251	Maione F	Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice.	The Journal of clinical investigation	2012	32
24251580	15251	Ball MK	Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α.	American journal of respiratory and critical care medicine	2014	33
24590072	15251	Spencer JA	Direct measurement of local oxygen concentration in the bone marrow of live animals.	Nature	2014	107
25063991	15251	Ong SG	HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.	Cardiovascular research	2014	21
26098368	15251	Kimura W	Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart.	Nature	2015	30
15841216	15368	Duranski MR	Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver.	The Journal of clinical investigation	2005	196
17339405	15368	Deshane J	Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism.	The Journal of experimental medicine	2007	68
17525142	15368	Wang J	Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.	Brain 	2007	96
20404253	15368	Wang G	Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.	Circulation	2010	67
21289052	15368	Wu QQ	Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.	American journal of physiology. Renal physiology	2011	45
21518986	15368	Vergadi E	Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.	Circulation	2011	43
22728935	15368	Paiva CN	Oxidative stress fuels Trypanosoma cruzi infection in mice.	The Journal of clinical investigation	2012	33
24366077	15368	Linzke N	Carbon monoxide promotes proliferation of uterine natural killer cells and remodeling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant mice.	Hypertension	2014	20
25593219	15368	Sun C	Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2.	Journal of applied physiology	2015	18
11375415	15894	Cybulsky MI	A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.	The Journal of clinical investigation	2001	209
17962481	15894	Leal EC	Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.	Investigative ophthalmology and visual science	2007	67
18202748	15894	Nishimura S	In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue.	The Journal of clinical investigation	2008	72
19614983	15894	Dvoriantchikova G	Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury.	The European journal of neuroscience	2009	47
21926464	15894	Fisher DT	IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.	The Journal of clinical investigation	2011	47
22706307	15894	Li W	Intravital 2-photon imaging of leukocyte trafficking in beating heart.	The Journal of clinical investigation	2012	32
24576947	15894	Tabet F	HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.	Nature communications	2014	56
16556916	16392	Yang L	Isl1Cre reveals a common Bmp pathway in heart and limb development.	Development	2006	81
17258700	16392	Sun Y	Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells.	Developmental biology	2007	95
18568026	16392	Zhou B	Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart.	Nature	2008	289
19531353	16392	Harel I	Distinct origins and genetic programs of head muscle satellite cells.	Developmental cell	2009	56
19833966	16392	Domian IJ	Generation of functional ventricular heart muscle from mouse ventricular progenitor cells.	Science	2009	80
15194740	16493	Brunet S	Heterogeneous expression of repolarizing, voltage-gated K+ currents in adult mouse ventricles.	The Journal of physiology	2004	74
16772329	16493	Olson TM	Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.	Human molecular genetics	2006	126
7596435	16542	Shalaby F	Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.	Nature	1995	649
7681362	16542	Millauer B	High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.	Cell	1993	268
8107827	16542	Millauer B	Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.	Nature	1994	162
9200616	16542	Shalaby F	A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis.	Cell	1997	127
11577199	16542	Matsumoto K	Liver organogenesis promoted by endothelial cells prior to vascular function.	Science	2001	153
12480817	16542	Ushio-Fukai M	Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.	Circulation research	2002	128
15644447	16542	Sakurai Y	Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	94
16166582	16542	Ema M	Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors.	Blood	2006	99
17084363	16542	Kattman SJ	Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages.	Developmental cell	2006	247
18432194	16542	Yang L	Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population.	Nature	2008	432
18443294	16542	Purhonen S	Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.	Proceedings of the National Academy of Sciences of the United States of America	2008	121
18462699	16542	Lee D	ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification.	Cell stem cell	2008	106
18625891	16542	Narazaki G	Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.	Circulation	2008	119
19265665	16542	Hooper AT	Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells.	Cell stem cell	2009	161
20073084	16542	Kojima T	Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum.	Stem cells	2010	68
20434959	16542	Lanahan AA	VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis.	Developmental cell	2010	91
21295278	16542	Kattman SJ	Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.	Cell stem cell	2011	318
21596799	16542	Mauritz C	Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction.	European heart journal	2011	38
21880786	16542	Stenzel D	Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis.	Development	2011	36
23575676	16542	Hayashi M	VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation.	Nature communications	2013	32
23639442	16542	Lanahan A	The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.	Developmental cell	2013	53
24401374	16542	Fantin A	Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.	Development	2014	32
11287958	16590	Orlic D	Bone marrow cells regenerate infarcted myocardium.	Nature	2001	800
15034594	16590	Balsam LB	Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.	Nature	2004	335
16823487	16590	Fazel S	Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.	The Journal of clinical investigation	2006	143
17123591	16590	Wu SM	Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart.	Cell	2006	171
18308948	16590	Fransioli J	Evolution of the c-kit-positive cell response to pathological challenge in the myocardium.	Stem cells	2008	50
18988802	16590	Nigrovic PA	Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.	The American journal of pathology	2008	70
19193854	16590	Tallini YN	c-kit expression identifies cardiovascular precursors in the neonatal heart.	Proceedings of the National Academy of Sciences of the United States of America	2009	67
19341866	16590	Li Z	Imaging survival and function of transplanted cardiac resident stem cells.	Journal of the American College of Cardiology	2009	75
19901187	16590	Fischer KM	Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase.	Circulation	2009	85
19968998	16590	Limana F	Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid.	Journal of molecular and cellular cardiology	2010	42
20421520	16590	Zaruba MM	Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts.	Circulation	2010	75
20876651	16590	Yokomizo T	Three-dimensional cartography of hematopoietic clusters in the vasculature of whole mouse embryos.	Development	2010	60
21516491	16590	Li Q	Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models.	Basic research in cardiology	2011	42
23549981	16590	Hong KU	A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice.	Basic research in cardiology	2013	35
24805242	16590	van Berlo JH	c-kit+ cells minimally contribute cardiomyocytes to the heart.	Nature	2014	149
24806457	16590	Hong KU	c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart.	PloS one	2014	39
24945383	16590	Smith AJ	Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart.	Nature protocols	2014	21
25300435	16590	Cheng K	Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction.	Journal of the American Heart Association	2014	23
26515110	16590	Sultana N	Resident c-kit(+) cells in the heart are not cardiac stem cells.	Nature communications	2015	29
8182121	16835	Ishibashi S	Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.	The Journal of clinical investigation	1994	135
9734366	16835	Gu L	Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.	Molecular cell	1998	269
10922059	16835	Hajra L	The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation.	Proceedings of the National Academy of Sciences of the United States of America	2000	133
12032330	16835	Joseph SB	Synthetic LXR ligand inhibits the development of atherosclerosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2002	187
16127462	16835	Vikramadithyan RK	Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.	The Journal of clinical investigation	2005	66
16211093	16835	Mullick AE	Modulation of atherosclerosis in mice by Toll-like receptor 2.	The Journal of clinical investigation	2005	149
17932314	16835	Al-Aly Z	Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.	Arteriosclerosis, thrombosis, and vascular biology	2007	88
18250194	16835	Mullick AE	Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.	The Journal of experimental medicine	2008	52
18274671	16835	Lu H	Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.	The Journal of clinical investigation	2008	55
19893012	16835	Paulson KE	Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.	Circulation research	2010	69
21252156	16835	Rateri DL	Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/- mice.	Circulation research	2011	48
21690490	16835	Maganto-García E	Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.	Circulation	2011	38
22699504	16835	Fukuda D	Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.	Proceedings of the National Academy of Sciences of the United States of America	2012	35
22927427	16835	Castellano JM	Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis.	Proceedings of the National Academy of Sciences of the United States of America	2012	40
23288159	16835	Marquart TJ	Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.	Arteriosclerosis, thrombosis, and vascular biology	2013	46
23426179	16835	Klingenberg R	Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.	The Journal of clinical investigation	2013	61
26903003	16835	Seldin MM	Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.	Journal of the American Heart Association	2016	19
12690199	16971	Boucher P	LRP: role in vascular wall integrity and protection from atherosclerosis.	Science	2003	162
14617754	16971	Yepes M	Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.	The Journal of clinical investigation	2003	162
15294142	16971	Deane R	LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.	Neuron	2004	232
18626063	16971	Lillis AP	LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.	Physiological reviews	2008	183
19098903	16971	Bell RD	SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.	Nature cell biology	2009	80
21995440	16971	Kovac A	Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide.	Journal of neuroinflammation	2011	40
23152628	16971	Kanekiyo T	LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.	The Journal of neuroscience 	2012	46
24467845	16971	Qosa H	Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.	Neuropharmacology	2014	27
26619118	16971	Storck SE	Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.	The Journal of clinical investigation	2016	22
9590175	17395	Vu TH	MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.	Cell	1998	350
11485970	17395	Creemers EE	Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?	Circulation research	2001	102
11567062	17395	Asahi M	Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.	The Journal of neuroscience 	2001	225
12196576	17395	Noble LJ	Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.	The Journal of neuroscience 	2002	107
12960961	17395	Wang X	Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.	Nature medicine	2003	124
15146242	17395	Gursoy-Ozdemir Y	Cortical spreading depression activates and upregulates MMP-9.	The Journal of clinical investigation	2004	82
15764676	17395	Gidday JM	Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.	American journal of physiology. Heart and circulatory physiology	2005	123
15800021	17395	Wang J	Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.	Brain 	2005	88
16126817	17395	Lindsey ML	Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.	American journal of physiology. Heart and circulatory physiology	2006	78
17301159	17395	Svedin P	Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia.	The Journal of neuroscience 	2007	70
18632868	17395	Wang P	Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain.	Journal of virology	2008	51
19997118	17395	Bauer AT	Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.	Journal of cerebral blood flow and metabolism 	2010	56
20534467	17395	Jujo K	CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.	Proceedings of the National Academy of Sciences of the United States of America	2010	59
21933988	17395	Kowluru RA	Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.	Diabetes	2011	40
22918978	17395	Chiao YA	Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.	Cardiovascular research	2012	36
23281396	17395	Seo JH	Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury.	The Journal of clinical investigation	2013	29
23674483	17395	Li P	Adoptive regulatory T-cell therapy protects against cerebral ischemia.	Annals of neurology	2013	39
24570026	17395	Carmona-Rivera C	Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2.	Annals of the rheumatic diseases	2015	40
22465693	17868	Fraysse B	Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.	Journal of molecular and cellular cardiology	2012	31
12623879	17888	Sanbe A	Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter.	Circulation research	2003	104
19893015	17888	Matkovich SJ	MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.	Circulation research	2010	110
24371138	17888	Das A	Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.	The Journal of biological chemistry	2014	23
19106098	17906	Scruggs SB	Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation.	The Journal of biological chemistry	2009	59
22426213	17906	Sheikh F	Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease.	The Journal of clinical investigation	2012	58
23095280	17906	Warren SA	Myosin light chain phosphorylation is critical for adaptation to cardiac stress.	Circulation	2012	32
7904557	18091	Lints TJ	Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants.	Development	1993	127
17350578	18091	Prall OW	An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation.	Cell	2007	161
7505721	18125	Huang PL	Targeted disruption of the neuronal nitric oxide synthase gene.	Cell	1993	210
11907582	18125	Barouch LA	Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.	Nature	2002	193
14583343	18125	Kleinbongard P	Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals.	Free radical biology and medicine	2003	117
16368881	18125	Kleinbongard P	Red blood cells express a functional endothelial nitric oxide synthase.	Blood	2006	97
21788351	18125	Nogueira L	(-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle.	The Journal of physiology	2011	41
24305053	18125	Whiteus C	Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period.	Nature	2014	23
7545787	18127	Huang PL	Hypertension in mice lacking the gene for endothelial nitric oxide synthase.	Nature	1995	351
8784243	18127	Huang Z	Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine.	Journal of cerebral blood flow and metabolism 	1996	111
8917564	18127	Shesely EG	Elevated blood pressures in mice lacking endothelial nitric oxide synthase.	Proceedings of the National Academy of Sciences of the United States of America	1996	217
9466966	18127	Rudic RD	Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.	The Journal of clinical investigation	1998	141
9616228	18127	Murohara T	Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.	The Journal of clinical investigation	1998	220
11120759	18127	Matoba T	Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice.	The Journal of clinical investigation	2000	133
11457755	18127	Duplain H	Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.	Circulation	2001	115
11457855	18127	Razani B	Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.	The Journal of biological chemistry	2001	338
11901190	18127	Zou MH	Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite.	The Journal of clinical investigation	2002	148
15001455	18127	Kawashima S	Dysfunction of endothelial nitric oxide synthase and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2004	74
15265871	18127	Zou MH	Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species.	The Journal of biological chemistry	2004	126
16043715	18127	Yu J	Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve.	Proceedings of the National Academy of Sciences of the United States of America	2005	109
17158223	18127	Hsu LL	Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.	Blood	2007	92
17179207	18127	Suliman HB	A new activating role for CO in cardiac mitochondrial biogenesis.	Journal of cell science	2007	66
17456755	18127	Kanetsuna Y	Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice.	The American journal of pathology	2007	64
17785417	18127	Mattagajasingh I	SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase.	Proceedings of the National Academy of Sciences of the United States of America	2007	212
19213952	18127	Yin C	A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.	Circulation research	2009	51
19417091	18127	Durrant JR	Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase.	The Journal of physiology	2009	73
19767531	18127	Yang YM	eNOS uncoupling and endothelial dysfunction in aged vessels.	American journal of physiology. Heart and circulatory physiology	2009	82
19822799	18127	Marchesi C	Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome.	Hypertension	2009	58
20431061	18127	Dai X	Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis.	Circulation research	2010	49
21030723	18127	Giacco F	Oxidative stress and diabetic complications.	Circulation research	2010	590
21045790	18127	Nakagawa T	Endothelial dysfunction as a potential contributor in diabetic nephropathy.	Nature reviews. Nephrology	2011	47
21127294	18127	Austin SA	Endothelial nitric oxide modulates expression and processing of amyloid precursor protein.	Circulation research	2010	45
22997257	18127	Yuen DA	eNOS deficiency predisposes podocytes to injury in diabetes.	Journal of the American Society of Nephrology 	2012	33
24357508	18127	Katusic ZS	Endothelial nitric oxide: protector of a healthy mind.	European heart journal	2014	27
7958863	18591	Levéen P	Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities.	Genes and development	1994	208
9211853	18591	Lindahl P	Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.	Science	1997	432
11331305	18591	Hellström M	Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.	The Journal of cell biology	2001	226
12351455	18591	Hammes HP	Pericytes and the pathogenesis of diabetic retinopathy.	Diabetes	2002	92
12897053	18591	Lindblom P	Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall.	Genes and development	2003	134
14561699	18591	Abramsson A	Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.	The Journal of clinical investigation	2003	134
15084468	18591	Bjarnegård M	Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities.	Development	2004	80
12727920	18596	Bergers G	Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.	The Journal of clinical investigation	2003	328
15557593	18596	Pietras K	A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.	Journal of clinical oncology 	2005	111
15902258	18596	Choi MH	Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II.	Nature	2005	101
16113679	18596	Song S	PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.	Nature cell biology	2005	160
18948621	18596	Mellgren AM	Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations.	Circulation research	2008	64
19801450	18596	Guignabert C	Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.	American journal of physiology. Lung cellular and molecular physiology	2009	53
20944625	18596	Daneman R	Pericytes are required for blood-brain barrier integrity during embryogenesis.	Nature	2010	322
21664579	18596	Olson LE	PDGFRβ signaling regulates mural cell plasticity and inhibits fat development.	Developmental cell	2011	44
23128780	18596	Birbrair A	Skeletal muscle pericyte subtypes differ in their differentiation potential.	Stem cell research	2013	31
26952098	18596	Sakuma R	Brain pericytes serve as microglia-generating multipotent vascular stem cells following ischemic stroke.	Journal of neuroinflammation	2016	11
10751361	18613	Hashizume H	Openings between defective endothelial cells explain tumor vessel leakiness.	The American journal of pathology	2000	255
11827998	18613	Graesser D	Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.	The Journal of clinical investigation	2002	101
12689916	18613	Newman PJ	Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology.	Arteriosclerosis, thrombosis, and vascular biology	2003	92
16614004	18613	Wang X	The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling.	Stem cells	2006	72
16625243	18613	Santel A	A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium.	Gene therapy	2006	80
17160391	18613	Chang YS	Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.	Cancer chemotherapy and pharmacology	2007	101
18040029	18613	Chang EI	Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia.	Circulation	2007	56
18682734	18613	Walls JR	Three-dimensional analysis of vascular development in the mouse embryo.	PloS one	2008	55
19351748	18613	Lee JW	Surgical stress promotes tumor growth in ovarian carcinoma.	Clinical cancer research 	2009	48
21106942	18613	Russell JL	A dynamic notch injury response activates epicardium and contributes to fibrosis repair.	Circulation research	2011	49
7910522	18671	Schinkel AH	Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.	Cell	1994	251
8647944	18671	Schinkel AH	P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.	The Journal of clinical investigation	1996	132
19056914	18671	Polli JW	An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (N-{3-chloro-4-(3-fluorobenzyl)oxyphenyl}-6-5-({2-(methylsulfonyl)ethylamino}methyl)-2-furyl-4-quinazolinamine; GW572016).	Drug metabolism and disposition	2009	62
20952483	18671	Agarwal S	The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain.	The Journal of pharmacology and experimental therapeutics	2011	46
19959778	18821	Zhang T	Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.	Circulation research	2010	40
25640239	18821	Anderson DM	A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.	Cell	2015	102
10377439	19013	Leone TC	A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.	Proceedings of the National Academy of Sciences of the United States of America	1999	222
11781357	19013	Finck BN	The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus.	The Journal of clinical investigation	2002	212
12552126	19013	Finck BN	A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.	Proceedings of the National Academy of Sciences of the United States of America	2003	133
15456881	19013	Huss JM	Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.	Molecular and cellular biology	2004	143
15578089	19013	Li AC	Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.	The Journal of clinical investigation	2004	124
17130488	19013	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	99
18037994	19013	Burkart EM	Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.	The Journal of clinical investigation	2007	86
18462747	19013	Madrazo JA	The PPAR trio: regulators of myocardial energy metabolism in health and disease.	Journal of molecular and cellular cardiology	2008	80
19451348	19013	Yan J	Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity.	Circulation	2009	52
19549860	19013	Crawford PA	Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation.	Proceedings of the National Academy of Sciences of the United States of America	2009	77
20522803	19013	Banke NH	Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha.	Circulation research	2010	46
20852389	19013	Son NH	PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.	The Journal of clinical investigation	2010	58
21115502	19013	Planavila A	Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.	Cardiovascular research	2011	42
24482374	19013	Cheang WS	Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.	Arteriosclerosis, thrombosis, and vascular biology	2014	27
26838599	19013	Montagner A	Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.	Gut	2016	20
9606187	19091	Pfeifer A	Defective smooth muscle regulation in cGMP kinase I-deficient mice.	The EMBO journal	1998	115
23285278	19091	Bucci M	cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation.	PloS one	2012	35
16213210	20191	Lehnart SE	Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.	Cell	2005	138
16825580	20191	Liu N	Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.	Circulation research	2006	79
17872467	20191	Cerrone M	Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.	Circulation research	2007	84
19096022	20191	Fernández-Velasco M	Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.	Circulation research	2009	45
19603549	20191	Chelu MG	Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.	The Journal of clinical investigation	2009	131
19835880	20191	Hilliard FA	Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.	Journal of molecular and cellular cardiology	2010	72
20080623	20191	Fauconnier J	Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy.	Proceedings of the National Academy of Sciences of the United States of America	2010	61
20224043	20191	Uchinoumi H	Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.	Circulation research	2010	41
20479242	20191	Kushnir A	Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure.	Proceedings of the National Academy of Sciences of the United States of America	2010	45
21099115	20191	Shan J	Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice.	The Journal of clinical investigation	2010	69
21099118	20191	Shan J	Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice.	The Journal of clinical investigation	2010	53
22511749	20191	Respress JL	Role of RyR2 phosphorylation at S2814 during heart failure progression.	Circulation research	2012	53
23363625	20191	Pereira L	Epac2 mediates cardiac β1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia.	Circulation	2013	40
23507255	20191	Marx SO	Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases.	Journal of molecular and cellular cardiology	2013	25
24398018	20191	Li N	Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model.	Circulation	2014	26
24441828	20191	Chen W	The ryanodine receptor store-sensing gate controls Ca2+ waves and Ca2+-triggered arrhythmias.	Nature medicine	2014	43
26169582	20191	Xie W	Mitochondrial oxidative stress promotes atrial fibrillation.	Scientific reports	2015	26
22647976	20271	Davis RP	Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.	Circulation	2012	69
24895455	20271	Shy D	PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function.	Circulation	2014	22
7596437	21687	Sato TN	Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.	Nature	1995	306
7958865	21687	Dumont DJ	Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.	Genes and development	1994	195
9096345	21687	Schlaeger TM	Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	1997	140
12371954	21687	Sutton TA	Microvascular endothelial injury and dysfunction during ischemic acute renal failure.	Kidney international	2002	105
12684225	21687	Sutton TA	Injury of the renal microvascular endothelium alters barrier function after ischemia.	American journal of physiology. Renal physiology	2003	79
21123492	21687	Basile DP	Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury.	American journal of physiology. Renal physiology	2011	65
25359852	21687	Rasmussen AL	Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance.	Science	2014	51
14595408	21954	Okazaki T	Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.	Nature medicine	2003	76
17641226	21954	Stelzer JE	Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation.	Circulation research	2007	74
20703310	21956	Prasad KM	Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.	Gene therapy	2011	42
16537787	22138	Hoshijima M	Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures.	American journal of physiology. Heart and circulatory physiology	2006	83
18252826	22138	Zoghbi ME	Three-dimensional structure of vertebrate cardiac muscle myosin filaments.	Proceedings of the National Academy of Sciences of the United States of America	2008	94
19269976	22138	Shaffer JF	The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner.	The Journal of biological chemistry	2009	84
23283722	22138	Hamdani N	Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation.	Circulation research	2013	35
1592003	22339	Breier G	Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.	Development	1992	158
2478587	22339	Connolly DT	Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.	The Journal of clinical investigation	1989	201
10021335	22339	Gerber HP	VEGF is required for growth and survival in neonatal mice.	Development	1999	223
10416597	22339	Gorski DH	Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.	Cancer research	1999	169
10494799	22339	Ferrara N	Molecular and biological properties of vascular endothelial growth factor.	Journal of molecular medicine	1999	166
10952892	22339	Miquerol L	Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.	Development	2000	119
11827992	22339	Stalmans I	Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms.	The Journal of clinical investigation	2002	131
11839630	22339	Iwaguro H	Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration.	Circulation	2002	86
12086669	22339	Mukouyama YS	Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin.	Cell	2002	121
12087404	22339	Gerber HP	VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.	Nature	2002	147
12381667	22339	Ruhrberg C	Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.	Genes and development	2002	235
12814555	22339	Lammert E	Role of VEGF-A in vascularization of pancreatic islets.	Current biology 	2003	102
12954648	22339	Sanchez T	Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.	The Journal of biological chemistry	2003	116
14576200	22339	Kelly BD	Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.	Circulation research	2003	154
14739163	22339	Kinnaird T	Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.	Circulation research	2004	277
14966561	22339	Ozawa CR	Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.	The Journal of clinical investigation	2004	122
15184386	22339	Furuyama T	Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice.	The Journal of biological chemistry	2004	107
15339668	22339	Chang CP	A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis.	Cell	2004	117
15790954	22339	Ouchi N	AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle.	Circulation research	2005	71
16049343	22339	Al-Shabrawey M	Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.	The American journal of pathology	2005	74
16172161	22339	Baffert F	Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling.	American journal of physiology. Heart and circulatory physiology	2006	100
16172168	22339	Kamba T	VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.	American journal of physiology. Heart and circulatory physiology	2006	194
16251428	22339	Marneros AG	Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function.	The American journal of pathology	2005	73
16278208	22339	Liang WC	Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.	The Journal of biological chemistry	2006	100
16567591	22339	Izumiya Y	Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.	Hypertension	2006	80
17016557	22339	Mancuso MR	Rapid vascular regrowth in tumors after reversal of VEGF inhibition.	The Journal of clinical investigation	2006	206
17191092	22339	Chen RR	Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation.	Pharmaceutical research	2007	83
17322368	22339	van Amerongen MJ	Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.	The American journal of pathology	2007	118
17719546	22339	Lee S	Autocrine VEGF signaling is required for vascular homeostasis.	Cell	2007	286
18293091	22339	Nagy JA	Vascular permeability, vascular hyperpermeability and angiogenesis.	Angiogenesis	2008	125
19013462	22339	Scaldaferri F	VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.	Gastroenterology	2009	67
19338032	22339	Shen X	Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice.	Journal of orthopaedic research 	2009	47
19768732	22339	Bai Y	Müller cell-derived VEGF is a significant contributor to retinal neovascularization.	The Journal of pathology	2009	61
19841260	22339	Saint-Geniez M	An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris.	Proceedings of the National Academy of Sciences of the United States of America	2009	98
19955410	22339	Papapetropoulos A	Hydrogen sulfide is an endogenous stimulator of angiogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2009	120
20033380	22339	Hellberg C	PDGF and vessel maturation.	Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer	2010	53
20501654	22339	Long J	Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.	The Journal of biological chemistry	2010	82
20530741	22339	Wang J	Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage.	Diabetes	2010	65
21102434	22339	Ricci-Vitiani L	Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.	Nature	2010	321
21784979	22339	Oladipupo S	VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting.	Proceedings of the National Academy of Sciences of the United States of America	2011	40
21808036	22339	Webber MJ	Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair.	Proceedings of the National Academy of Sciences of the United States of America	2011	54
22653056	22339	Argaw AT	Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.	The Journal of clinical investigation	2012	97
25362254	22339	Kikuchi R	An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease.	Nature medicine	2014	28
15800627	105675	Baines CP	Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.	Nature	2005	589
17512507	105675	Lim SY	Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.	Cardiovascular research	2007	60
17694179	105675	Nakayama H	Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure.	The Journal of clinical investigation	2007	126
18345011	105675	Millay DP	Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy.	Nature medicine	2008	101
20364102	105675	Carreira RS	Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells.	Autophagy	2010	58
20668412	105675	Quinsay MN	Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore.	Autophagy	2010	47
21212461	105675	Hafner AV	Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy.	Aging	2010	130
23788623	105675	Thomas RL	Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure.	Genes and development	2013	41
24768964	105675	Gutiérrez-Aguilar M	Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition.	Journal of molecular and cellular cardiology	2014	22
17878306	107869	Elrod JW	Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function.	Proceedings of the National Academy of Sciences of the United States of America	2007	247
19704099	107869	Minamishima S	Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice.	Circulation	2009	65
20067586	107869	Gadalla MM	Hydrogen sulfide as a gasotransmitter.	Journal of neurochemistry	2010	89
21808008	107869	Suzuki K	Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function.	Proceedings of the National Academy of Sciences of the United States of America	2011	70
23704251	107869	Wang K	Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.	Circulation	2013	36
23704252	107869	Mani S	Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis.	Circulation	2013	45
12676814	108058	Zhang T	The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.	Circulation research	2003	159
17124532	108058	Wagner S	Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels.	The Journal of clinical investigation	2006	168
19808479	108058	Wagner S	Ca/calmodulin kinase II differentially modulates potassium currents.	Circulation. Arrhythmia and electrophysiology	2009	45
23619294	108058	Kooij V	Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts.	Journal of molecular and cellular cardiology	2013	26
26726877	108058	Zhang T	CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.	Nature medicine	2016	32
17478727	108078	Mehta JL	Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.	Circulation research	2007	85
23305858	108078	Ding Z	Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g.	International journal of cardiology	2013	30
23935243	108078	Pirillo A	LOX-1, OxLDL, and atherosclerosis.	Mediators of inflammation	2013	41
18835932	108079	Xie Z	Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes.	Diabetes	2008	52
19188503	108079	Wang Y	AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.	Circulation	2009	49
20124121	108079	Dong Y	Reduction of AMP-activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo.	Circulation	2010	67
20167927	108079	Wang S	AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.	Circulation research	2010	103
20299472	108079	Dong Y	Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo.	Diabetes	2010	49
22561688	108079	Wang S	Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo.	Nature medicine	2012	46
7761854	110355	Koch WJ	Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.	Science	1995	151
17008600	110355	Matkovich SJ	Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.	Circulation research	2006	73
17060617	110355	Rajagopal K	Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes.	Proceedings of the National Academy of Sciences of the United States of America	2006	72
17482545	110355	Whalen EJ	Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2.	Cell	2007	119
18635825	110355	Raake PW	G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.	Circulation research	2008	79
20576935	110355	Casey LM	Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.	Circulation research	2010	60
20800067	110355	Rengo G	GRK2 as a novel gene therapy target in heart failure.	Journal of molecular and cellular cardiology	2011	37
21518983	110355	Ciccarelli M	G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.	Circulation	2011	38
22882301	110355	Thal DM	Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility.	ACS chemical biology	2012	37
23467820	110355	Chen M	Prodeath signaling of G protein-coupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting.	Circulation research	2013	45
25739765	110355	Schumacher SM	Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.	Science translational medicine	2015	21
12049719	110454	de Bruijn MF	Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta.	Immunity	2002	90
15737933	110454	Ottersbach K	The murine placenta contains hematopoietic stem cells within the vascular labyrinth region.	Developmental cell	2005	95
19620770	110454	Matsuura K	Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice.	The Journal of clinical investigation	2009	62
23166366	110454	Nemir M	The Notch pathway controls fibrotic and regenerative repair in the adult heart.	European heart journal	2014	29
23463815	110454	Dey D	Dissecting the molecular relationship among various cardiogenic progenitor cells.	Circulation research	2013	33
23801066	110454	Duran JM	Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms.	Circulation research	2013	44
25980517	110454	Noseda M	PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium.	Nature communications	2015	22
18427128	110784	Guo C	Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.	Circulation	2008	57
23594590	110784	Schäfer N	Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.	European heart journal	2013	28
26015449	110784	DeMarco VG	Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.	Hypertension	2015	21
26879229	110784	Jia G	Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females.	Circulation research	2016	17
16966370	112405	Takeda K	Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2.	Molecular and cellular biology	2006	108
17646578	112405	Takeda K	Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.	Circulation	2007	69
19217150	112405	Mazzone M	Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.	Cell	2009	204
19720742	112405	Minamishima YA	A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo.	Molecular and cellular biology	2009	48
21983962	112405	Takeda Y	Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis.	Nature	2011	79
26976644	112405	Kapitsinou PP	The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.	Molecular and cellular biology	2016	11
27143681	112405	Dai Z	Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.	Circulation	2016	12
11668599	121021	Ozerdem U	NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.	Developmental dynamics 	2001	156
20599895	121021	Huang FJ	Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.	Developmental biology	2010	49
22095829	121021	Dar A	Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb.	Circulation	2012	48
24107994	121021	Kunisaki Y	Arteriolar niches maintain haematopoietic stem cell quiescence.	Nature	2013	172
20596014	140781	Hang CT	Chromatin regulation by Brg1 underlies heart muscle development and disease.	Nature	2010	138
25119045	140781	Han P	A long noncoding RNA protects the heart from pathological hypertrophy.	Nature	2014	78
